Mandatory Disclosure Is The New Reality
Client Alert | less than 1 min read | 11.20.08
If you missed Tuesday's important webinar on the new mandatory disclosure rule, the recorded session and powerpoint presentation are now available on our website. The panel provided in-depth analysis of the mandatory disclosure obligations on federal contractors and subcontractors for "significant overpayments," violations of federal criminal laws involving fraud, conflict of interest, bribery or gratuity violations, and violations of the civil False Claims Act and also provided practical guidance on how your company can meet the the major challenges in complying with this new rule.
Mandatory Disclosure: A New Reality - Click to access all webinar-related materials.
Insights
Client Alert | 5 min read | 04.13.26
EU Pharma Package: Global (Orphan) Marketing Authorization Compromise Proposal
In our fifth alert in this EU Pharma Package Series, we provided an analysis of the background and ongoing legal debates regarding the concept of the global marketing authorization (GMA). We discussed in particular the missed opportunities in the Pharma Package to further codify and clarify the GMA, in view of its central role in determining the regulatory data protection (RDP) rights of a medicinal product.
Client Alert | 4 min read | 04.10.26
CMS Finalizes Rate Notice for Medicare Parts C and D (CY 2027)
Client Alert | 2 min read | 04.10.26
Client Alert | 4 min read | 04.10.26
FTC Issues Five-Year Strategic Plan: What Businesses Need to Know
